Problem: Depression is a common disorder worldwide. Most patients are treated within primary care and antidepressant treatment is not recommended for people with mild depression. Physical activity has been shown to alleviate depression but it is not known whether the less vigorous activity of walking -a potentially widely acceptable and safe intervention -confers such benefit.
Introduction
Depression is an illness or mood disorder with a variety of symptoms, the most defining being an inexplicable, enduring feeling of sadness (loss of positive affect). It is categorised as mild, moderate or severe depending upon the number and severity of the symptoms (WHO, 2010) . It is a common mental health problem, estimated in 2000 to be the fourth leading cause of disease burden worldwide (WHO, 2003; Ustun, Ayuso-Mateos, Chatterji, Mathers, & Murray, 2004) . It causes a level of morbidity comparable to or worse than other common chronic diseases such as asthma and diabetes (Moussavi et al., 2007) . In the UK over 75% of patients with depression are treated solely within primary care (NICE, 2010) where prevalence is estimated at 7% (Ostler et al., 2001) .
Depression is commonly treated with anti-depressant medications, psychological therapies depression", and another systematic review of the effect of exercise in clinically depressed adults by Krogh and colleagues found that there was a short-term positive effect of exercise on depression but no positive long-term effect (Krogh, Nordentoft, Sterne, & Lawlor, 2011) . For patients with persistent sub-threshold or mild to moderate depression, current UK NICE guidelines (NICE, 2010) recommend structured physical activity programmes, individual guided self-help based on cognitive behavior therapy (CBT) principles and/or computerised CBT as treatment choices. It is recommended that the physical activity programmes are group based and led by a trained practitioner thrice weekly for 45 minutes to one hour for a period of 10 to 14 weeks.
Walking is a form of physical activity that has the potential to alleviate depression. When taken outdoors, the addition of being able to observe or experience an attractive natural environment has been shown to have a restorative effect, decreasing levels of stress, (Ulrich, 1983; Kaplan & Kaplan, 1989; Hartig, Mang & Evans, 1991) which could contribute to reducing symptoms of depression. Walking has the advantages of being easily undertaken by most people, incurring little or no financial cost, having minimal risk of adverse effects and being relatively easy to incorporate into daily living. Consequently, walking is promoted in many developed countries throughout the world (Paths for All, 2011; 10,000 Steps Project, 2011; Centers for Disease Control and Prevention, 2011; Health Canada, 2011; International Longevity Center-USA, 2011; Natural England, 2011; NHS Choices Information, 2011; Welsh Assembly Government, 2011) to counteract increasingly sedentary lifestyles and the health consequences of physical inactivity. While existing systematic literature reviews with meta-analyses (Mead et al., 2009; Lawlor et al., 2001; Krogh et al., 2011) have found positive, but not conclusive evidence, to support exercise as an intervention for depression, to our knowledge no review to date has evaluated the effectiveness of specific types of physical activity.
A variety of mechanisms to explain why physical activity might reduce depressive symptoms has been suggested (Craft & Perna, 2004) . These include biochemical (including endorphin and monoamine hypotheses), physiological (thermogenic, cardiovascular fitness, and sleep improvement hypotheses) and psychological and psychosocial hypotheses such as distraction, self-efficacy and enhancement of self-esteem (Sonstroem & Morgan, 1989) or increasing positive affect (White, Kendrick, & Yardley, 2009; Clark & Watson, 1991) .
Whichever mechanism or combination of mechanisms are responsible for physical activity reducing depressive symptoms, there is uncertainty regarding the optimum dose (duration and frequency of sessions, length of programme) and intensity and which specific type(s) of physical activity benefit depression (Mead et al., 2008) . It is not known whether walking is a form of physical activity that is sufficiently vigorous to stimulate sufficient biochemical or physiological changes to be an effective treatment for depression and whether walking interventions contribute to or diminish the overall effect sizes reported.
If the available evidence were able to demonstrate that walking is an effective physical activity for the treatment of depression, this knowledge could inform current recommendations and give health professionals greater confidence in the benefits of walking when advising patients who are depressed. We therefore carried out a systematic review of the existing literature to examine the effectiveness of walking as an intervention for alleviating depression in adults, and performed a meta-analysis on relevant data. Further, we considered walking outdoors, walking indoors and walking in a group.
Method

Literature search
The following key words were translated into the appropriate search syntax for the databases listed below:
(i) depression, depressive disorder, dysthymia, affective disorder, mood (ii) walk, walking, ambulatory, physical activity (iii) randomised controlled trial Searches were conducted with no language restrictions in electronic databases from the date the database was first published until August 2009, and updated in January 2012. The databases searched were: MEDLINE, AMED, EMBASE, PsycInfo, CINAHL, Physical Education Index, PsycArticles, Web of Science, SportDiscus, IBBS, and the Cochrane Central Register of Controlled Trials.
The Internet, the reference lists of relevant reviews of trials and of the trials themselves, and citations of the trials, were also searched. The investigators of past and ongoing trials were contacted to determine if any further data were available.
Trial selection
Trials were considered eligible if they reported a randomised, controlled trial, with adult (18 years or more) participants experiencing depression (as defined by the trial authors), who were treated with a walking intervention in any setting. We made an a priori decision to include all categories of depression (including post partum depression) with the exception of bipolar disorder because we did not wish the results to be contaminated by the natural progression from depression to mania in this disorder. Also excluded were trials with participants suffering mental health disorders other than depressive disorders and trials with participants selected on the basis of medical conditions (e.g. cancer). Eligible interventions were any structured or semi-structured walking treatment, indoors or outdoors, either as a single treatment or in combination with other treatment for depression. We excluded trials where some in the intervention group carried out an activity other than walking, such as higher-intensity jogging, and trials where participants could carry out other activities as well as walking, for example, stationary cycling and weight training; in these trials, data relating specifically to walking were not reported. We included trials where, in addition to the main intervention of walking, participants did warm up, cool down or other short periods of stretching as we believed these minor variations to a walking intervention were unlikely to influence any effect of walking on depression.
Data extraction
Titles of all the articles found using the search strategy described above were screened (half each by RR and AR) and papers that were clearly ineligible were discarded. The abstracts of the remaining trials were assessed and trials clearly not meeting the inclusion criteria discarded. Two review authors (RR and AR) accessed full copies of the remaining papers and independently assessed whether the trials met the inclusion criteria. Any differences of opinion were resolved by discussion among the review team. If necessary and possible, further clarification was sought from original authors. Data on the location of the trial, the methods -including trial quality, the participants, the nature of the intervention and control activities -and data relating to the trial outcomes were extracted (by either RR and AR and checked by the other) using a structured format. Where outcome data were not presented in the primary trials as required for this review, they were obtained from an earlier review by Mead et al. (2008) , acquired from authors or calculated from the available data as described in the Cochrane Handbook (The Cochrane Collaboration, 2011a).
Trial Quality
Information on the use of allocation concealment during randomisation, intention to treat analysis, sample size calculations and blinding of the assessors in the included trials was also extracted.
Comparisons
Results were analysed for all trials which compared a walking intervention with a control of no treatment, usual care or a treatment (such as cognitive behaviour therapy) that was also included as part of the intervention. They were also analysed in subgroups of the trials for outdoor walking, indoor walking and walking in a group.
Statistical analysis
Several different psychometric instruments are commonly used as outcome measures of depression and to be able to undertake a meta-analysis the standardised mean difference was calculated for each trial using RevMan5 software (Review Manager, 2011) . Both random effects and fixed effects models were employed to calculate the pooled effect sizes and the model which gave the most conservative result was used (The Cochrane Collaboration, 2011a).
Results
A total of 14,672 titles was retrieved, the abstracts of 364 were considered and the full texts of 103 trials were obtained (Figure 1 ). From these, seven separate trials fully met the inclusion criteria (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Bonnet, 2005; Knubben et al., 2007; McNeil, LeBlanc & Joyner, 1991; Mota-Pereira et al., 2011; Nguyen, 2008) . We decided to include one further trial (Gusi, Reyes, Gonzalez-Guerrero, Herrera & Garcia, 2008) , which recruited participants with a high body mass index in addition to patients who were depressed. This was included because the study had a large sample size thereby including a significant number of people with depression and had been conducted within a primary care setting. In addition, there is an association between high body mass index and depression (de Wit, van Straten, van Herten, Penninx, & Cuijpers, 2009 ). Sensitivity analysis was carried out to determine the impact of this decision. These eight studies provided a total of 341 participants randomised to treatment or control. Table 1 provides details of these trials included in the review, with information on the participants, the countries, the interventions and quality criteria. Information about the trials that were excluded is available from the first author on request.
Participants
In the included trials there was a variety of participant groups (postpartum women, students, women only and people from different age groups (50+, 60+, 20-70 years and elderly with mean age 72.5 years)); from a variety of settings (community or university campus settings, primary care, and inpatient or outpatient hospital care), with a range of severity of depression which was diagnosed in different ways (see Tables 1 and 2 ). One trial (Gusi et al. 2008 ) included participants who were overweight (64%) as well as those with a diagnosis of depression. We were unable to isolate the participants who had been recruited because of their high body mass index and they are included in the analysis.
The number of participants in each trial was generally quite small, ranging from 11 to 127 and with an average of 43.
Interventions
Walking was the primary intervention in all trials, but many variations existed. The main description of each intervention is given in Table 1 with further details in Table 3 . In four trials (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Gusi et al. 2008; Nguyen, 2008) participants had a warming up or cooling down period or other time when they did stretching exercises.
Three trials involved outdoor walking (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Gusi et al. 2008) , three indoor walking (Bonnet, 2005; Knubben et al., 2007; Nguyen, 2008 ) (with two using treadmills (Bonnet, 2005; Knubben et al., 2007) ) and two involved both indoor and outdoor walking (McNeil et al., 1991; Mota-Pereira et al., 2011) . In six trials (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Bonnet, 2005; Gusi et al. 2008; Knubben et al., 2007; Nguyen, 2008 ) the walking was led or supervised all the time; in one trial (McNeil et al., 1991) two of the three weekly walks were led, and in the final trial (MotaPereira et al., 2011) one of the five weekly walks was supervised. In three trials (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Gusi et al. 2008 ) participants walked as a group, although in one of these (Armstrong & Edwards, 2004) they undertook one of the three weekly walks individually.
In all but one trial (Nguyen, 2008) , a specific intensity of exercise was aimed for (Table   3 ). In four trials (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Bonnet, 2005; Knubben et al., 2007) this was based on heart rate, in one (Mota-Pereira et al., 2011) it was based on speed, and in two others the walk leaders aimed at achieving vigorous (McNeil et al., 1991) or brisk (Gusi et al. 2008) walking.
The lengths of the interventions varied from an average of 3.5 sessions over 6.2 days to six months and the length of individual sessions from 20 -50 minutes. In two of the trials (Knubben et al., 2007; Nguyen, 2008) walking sessions took place daily, in one (Mota-Pereira et al., 2011) participants were asked to walk on five days each week, in four (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; Gusi et al. 2008; McNeil et al., 1991 ) they aimed to walk on three days and in one (Bonnet, 2005) there were sessions on two days each week.
Completion rates of intervention participants
All eight trials provided data on intervention completion rates (Table 4) . Five had a completion rate equal to or greater than 90% (Armstrong & Edwards, 2003; Bonnet, 2005; Knubben et al., 2007; McNeil et al., 1991; Nguyen, 2008) ; Gusi et al. (2008) Table 4 .
Controls
The control groups varied in the activities in which they engaged (see Table 1 ). One trial (Knubben et al., 2007) used stretching and relaxation exercises as a control. Three had control groups with an element of social contact to control for the social aspects involved in the walking intervention; one (Armstrong & Edwards, 2004 ) had a weekly support group (for new mums with depression), one (McNeil et al., 1991) had one of the research team making social visits and in Nguyen"s (2008) trial the control group had sessions of talking (validation psychotherapy) with the researcher. One trial used a treatment (cognitive therapy) in the control group that was also used, in addition to walking, by the intervention group (Bonnet, 2005) . In the remaining two trials participants received usual care (Armstrong & Edwards, 2003; Gusi et al., 2008) .
Monitoring of fitness levels
Four trials recorded fitness measurements for all participants at the beginning and end of the trial: two estimated maximal oxygen uptake (VO 2 max -the maximum volume of oxygen that can be utilised in one minute during maximal or exhaustive exercise measured as millilitres of oxygen used in one minute per kilogram of body weight) (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004) , one (Mota-Pereira et al., 2011) measured heart rate and one (McNeil et al., 1991) the Cooper 12-minute walk test for aerobic capacity. Two trials recorded fitness measurements at the beginning and end of the trial for participants in the intervention arm only: Bonnet (2005) Gusi et al., 2008; Nguyen, 2008) did not measure participant fitness levels.
There were no apparent correlations between improvements in fitness and effect sizes (Table 5 ). In three trials (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004; McNeil et al., 1991) there was a significant improvement in fitness in the intervention arm at the end of the trial, but only two of these (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004) showed a significant effect of walking on depressive symptoms. McNeil et al. (1991) , in addition, found at the end of the trial a significant improvement in fitness for the walking group compared to the social contact control group. In the two trials with no significant positive impact on fitness on the participants in the walking arm, one (Bonnet, 2005) had no significant effect on depressive symptoms and one (Knubben et al., 2007) did. Mota-Pereira et al. (2011) found a significant reduction in depression scores in the walking arm compared to the control, but no difference in fitness between the two groups. Table 1 provides details of quality indicators (allocation concealment, intention to treat analysis, sample size calculations and blinding of assessors) reported in the trial papers. The quality of the trials was mixed, with one trial (Knubben et al., 2007) reporting and meeting all four quality indicators, one (Armstrong & Edwards, 2003) reporting three, two (Armstrong & Edwards, 2004; Gusi et al.,2008) reporting two and four (Bonnet, 2005; McNeil et al., 1991; Mota-Pereira et al., 2011; Nguyen, 2008) reporting one. Visual inspection of the Forest plot (Figure 2) does not indicate any clear difference in effect sizes related to reported quality criteria, with the possible exception of a larger effect size in the one study (Nguyen, 2008) which did not report allocation concealment, intention to treat analysis or blinding.
Quality of trials
Outcome measures
Several different outcome measures (Edinburgh Postnatal Depression Scale, Becks Depression Inventory, Becks Depression Inventory-ll, the Geriatric Depression Scale, the Hamilton Rating Scale for Depression and Bech-Rafaelsen Melancholy Scale) were used to detect any change in the levels of depression following the interventions in the included trials and these have been detailed in Table 2 .
Pooled standardised mean difference (effect size)
Data required for a meta-analysis were obtained for all eight trials and the results are shown in Figure 2 . Using a fixed effects model, which calculated a more conservative figure than a random effects model (The Cochrane Collaboration, 2011b), the pooled standardised mean difference was -0.86 [-1.12, -0.61], which is statistically significant and generally considered to be a large effect size (The Cochrane Collaboration, 2011c). Statistical heterogeneity, the extent to which the differences in the effect sizes of individual studies varied compared to what would be expected by chance alone (The Cochrane Collaboration, 2011d), was measured using I 2 and was high at 86%.
Including only the four trials with the highest quality indicators in a sensitivity analysis reduced the effect size slightly to -0.69 [-0.99, -0.39], but it remained statistically significant.
The largest trial (Gusi et al., 2008) differed from the others because the majority (64%) of participants was overweight and not necessarily depressed and the intervention included a larger range of non-walking exercises than the other trials. When the results of this trial were omitted from the meta-analysis the effect size became larger (-1.01 [-1.92, -0.11] using the more conservative result from a random effects model). In two trials (Armstrong & Edwards, 2003; Gusi et al., 2008 ) the participants walked as a group activity and the effect size for these trials was -0.60 [-0.96, -0.24 ].
Sub group analysis
Discussion
Our meta-analysis of eight randomised, controlled trials found that walking was an effective intervention for depression having an effect size of -0. In our sub-group analyses, the trials of group walking were a sub-set of the outdoor walking trials, and both of these sub-group analyses had the same effect size (-0.60). The combined effect size for the indoor walking trials was larger (-1.35) but two of these three trials
were of poorer quality, making it difficult to draw conclusions. Overall, the value of the subgroup analyses is limited by the small numbers of trials and participants, and further good quality walking trials are needed to determine whether there is added value, for example, to outdoor walking or walking in groups. The currently available evidence is inadequate to support the NICE (NICE 2010) recommendation for group exercise in cases where the exercise intervention is walking.
One of the strengths of this review was that it focused specifically on walking, thus a different set of trials has been reviewed than those in broader reviews of exercise as a treatment for depression. For example, the Mead Cochrane Review (Mead et al., 2008) comprised 23 trials comparing exercise with no treatment or control and two of these trials were eligible for the current review. The additional trials in our review included two with a population with postnatal depression, not included in the Mead review, and a further four, more recent trials.
In carrying out this systematic review the clinical and methodological heterogeneity of the trials and whether meta-analysis was an appropriate tool to use were carefully considered.
Trials were only included if the reported outcome measures had a validated depression assessment, walking was the main intervention activity, all participants in the intervention arm walked, and their only other activities were gentle stretching and short exercises that were unlikely to influence any effect of walking on depression. Indeed, in one of the trials (Knubben et al., 2007 ) the control arm used such exercises. Despite this, the trials that met the inclusion criteria were clearly diverse in terms of the characteristics of participants, the outcome measures, and the intervention and control details. However, calculations of overall effect sizes have been carried out in previous systematic reviews that include different types of exercise (Lawlor et al., 2001; Mead et al., 2009; Krogh et al., 2011; Stathopoulou et al., 2006) and a meta-analysis was presented in this paper to provide a figure that was indicative of effectiveness and could be compared with the results of broader reviews of exercise interventions. Nonetheless, we acknowledge that, despite our decision to use the statistical model that gave the most conservative effect size, the large, positive effect size reported here should be treated with some caution.
The generalisability of our findings is limited by the specific populations of the eight trials. The individual standardised mean differences of six of these had significant positive effects on depression, one had a non-significant positive effect and one a significant negative effect (see Figure 2 ). The participants in the two trials without significant positive effects (Bonnet, 2005; McNeil et al., 1991) were not recruited in clinical or health care settings, the interventions lasted for six weeks and involved walking at a moderate or vigorous pace. Further research would be needed to discover if recruitment methods or other factors were important influences on these trials" negative findings. The participants in three of the six trials with positive effects (Knubben et al., 2007; Mota-Pereira, 2011; Nguyen, 2008) came from psychiatric hospital inpatient and outpatient populations and in two trials they comprised women with postpartum depression (Armstrong & Edwards, 2003; Armstrong & Edwards, 2004) . The sixth, positive trial (Gusi et al., 2008) involved primary care patients with depression or high body mass index (conditions which are known to be associated with each other (de Wit et al., 2009) and given the large numbers of primary care patients with mild to moderate depression, (NICE, 2010; Ostler et al., 2001) further research is warranted to build on the results of this study.
While randomised, controlled trials offer the highest level of evidence for the effectiveness of treatments on specific diseases (Barton, 2000) they can be expensive and difficult to undertake in a methodologically rigorous manner (Hotopf, Lewis, & Normand, 1997) .
This would certainly be true for the topic addressed in this paper as walking interventions can take diverse forms (as this review highlighted) and depression can vary from person to person and over time (Thornicroft & Sartorius, 1993) . In addition, it is not possible to blind trial participants and eradicate all forms of bias such as demand bias (when the participant acts to please the researcher rather than in their usual way) (Orne, 1962) . Other levels of evidence have shown positive associations between walking and reducing depression. A summary of local health walk evaluations by the Countryside Agency (2005) found qualitative evidence that led walks had a "positive effect on walkers" mental health" (p28); two prospective cohort studies, one in older men with no past history of depression (Smith et al., 2010) and the other in older women (Heesch, Burton, & Brown, 2011) , found an inverse relationship between distances walked and future depressive symptoms; and a small, non-controlled trial of Nordic walking in patients with a history of depression (Suija et al., 2009) found an improvement in depressive symptoms. Such studies may add to the overall evidence base giving support to walking as a valuable treatment option. However, they would also need to be viewed within the context of their methodological limitations.
This review did not provide evidence that health professionals advising patients with depression to walk would have a positive effect on their depression, only that walking can be an effective treatment in research trial settings (Blumenthal & Ong, 2009) . How the effect sizes calculated in this and the broader reviews of exercise translate into clinical effectiveness is difficult to judge, but the positive result for walking interventions, which are also widely accessible and safe treatment options likely to deliver additional health benefits, offers strong support for further research into the clinical effectiveness of walking for patients with symptoms of depression, either as a sole intervention or as adjunctive therapy in both primary and secondary care settings. Ogilvie et al. (2007) found that general population interventions delivered at the level of individuals, households or groups were most effective at increasing walking and we hypothesise that health professionals, particularly in the primary care setting, are well placed to do this. For example, health professionals could "prescribe" walking by referring the patient to an exercise referral scheme in which walking was an option and an intermediary exercise specialist supported patients in deciding their best method to increase physical activity; make direct referrals to a local walking group; or offer brief advice to the patient during a consultation. There are inherent challenges in motivating people with depression. While our review did not aim to address questions of intervention adherence, we observed low attrition rates in the walking trials overall, which compared favourably with reported attrition in pharmaceutical trials with participants with depression (Cipriani et al., 2009; Kirsch et al., 2008) .
The review trial that reported 100% completion (Armstrong & Edwards, 2003) had used a range of techniques, including taking a register and participants keeping diaries, which may have influenced participants" attendance, although there do not appear to be any clear correlations between motivational techniques and completion rates (see Table 4 ). Other authors have indicated that pedometers (Baker et al. 2008; Bravata et al. 2007) or exercise consultations (Lowther et al. 2002) could be helpful. Research questions relating to health promotion and treatment adherence in the context of walking interventions for depression remain to be answered.
The way in which exercise affects depression and depressive symptoms is still a source of speculation (Faulkner & Carless, 2006) . The lack of correlation between fitness improvement and reduction in depression symptoms found in this review concurs with other work (Brosse, Sheets, Lett, & Blumenthal, 2002) . The recent and growing evidence that improvements in fitness are determined more by genetic factors than levels of exercise (Bouchard et al., 2011; Timmons et al., 2010) could explain this, at least in part, suggesting that it is not improvements from baseline fitness but other aspects of exercise, such as its intensity, perceived intensity, duration or contextual factors, that need to be measured to help explain the mechanism(s) behind physical activity"s positive effect on depression. However, the lack of obvious correlation between energy expenditure and effect sizes in the trials in this review and our overall finding that walking appears to reduce depression equally well as other more vigorous forms of exercise support arguments that the reduction in depressive symptoms is not directly related to energy expenditure either (King, Taylor & Haskell, 1993; Rethorst, Wipfli & Landers, 2009 ). In addition, while walking is often considered a more appropriate form of physical activity for older people, who may no longer be able to partake in vigorous activity, it appears from the evidence in this review to be beneficial to depressive symptoms in a wide range of ages. We would therefore hypothesise that mechanisms wholly dependent on energy expenditure are unlikely fully to explain how walking and other forms of exercise reduce depressive symptoms.
Conclusions
Walking has a statistically significant, large effect on the symptoms of depression in some populations but the current evidence base from randomised, controlled trials is limited.
Given that walking is potentially a widely accessible, safe and inexpensive treatment and in view of the high prevalence of depression in primary care patients, we recommend that future research should focus on evaluating walking interventions delivered in primary care settings.
Investigations are needed to establish the frequency, intensity, duration and type(s) of walking interventions -i.e., walking individually or in a group, indoors or outdoors -that are most effective and practical for primary care patients with depression. Future research should also aim to clarify the optimum role for health care professionals in delivering walking as an intervention, and which factors reliably enhance primary care patients" adherence to walking programmes.
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. Figure 1 . Identification of eligible papers from systematic searches Where the study was excluded for several reasons, only one reason has been included in these figures.
Records identified through database searching (x2) (n = 14667 )
Additional records identified through other sources (n = 5 )
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Full-text articles assessed for eligibility (n = 103)
Full-text articles excluded (n = 95) Trials included in quantitative synthesis (meta-analysis) (n = 8) Figure 2 . Meta-analysis of trials exploring the effects of walking as a treatment for depression 20-70 years, German speaking, able to walk. Diagnosed with a major depressive episode according to DSM-IV. Inclusion criteria included scores >12 on the Bech-Rafaelsen Melancholy Scale (BRMS).
10 days x 30 minutes daily of walking on a treadmill using an interval training pattern at 80% (220-age) heart rate 50% of the time and at half speed the remaining time.
10 days x 30 mins daily light stretching and relaxation exercises A,I,S,B 
